Meditech

Suki and Amwell Partner to Expand Access to AI Solutions that Empower Clinicians and Patients

Retrieved on: 
Tuesday, March 5, 2024

REDWOOD CITY, Calif., March 5, 2024 /PRNewswire/ -- Suki, the leader in voice artificial intelligence (AI) technology for healthcare, and Amwell, a leading hybrid care delivery enablement platform, partner to bring the AI-powered Suki Assistant to Amwell's Converge telehealth platform powering the digital care of more than 55 health plans representing more than 90 million people. This partnership showcases Amwell's leadership in leveraging cutting-edge technology to enhance outcomes for all stakeholders, from providers to payers.

Key Points: 
  • Amwell connects and enables providers across 2,000+ hospitals such as Cleveland Clinic, Northwell Health, and Intermountain Healthcare, to deliver greater access to more affordable, higher-quality care.
  • The platform excels in improving access and outcomes, featuring chat-based support, mental health programs, and in-visit enrollment for clinical programs.
  • Suki is a voice-enabled digital assistant for healthcare that leverages advanced AI to streamline administrative tasks.
  • "We're thrilled to partner with Amwell to power the AI voice experience of Converge so clinicians can focus on what matters most: their patients."

HHS’ Andrea Palm and ONC’s Micky Tripathi To Keynote The Sequoia Project and Carequality Joint Annual Meeting

Retrieved on: 
Thursday, November 9, 2023

The keynotes are set for its 2023 Annual Meeting with Carequality , the non-profit trusted framework for nationwide health information exchange.

Key Points: 
  • The keynotes are set for its 2023 Annual Meeting with Carequality , the non-profit trusted framework for nationwide health information exchange.
  • Tripathi will address perspectives from the Office of the National Coordinator for Health Information Technology (ONC).
  • Palm will discuss perspectives from HHS at 10 a.m. on Nov. 16 in San Diego.
  • The Sequoia Project and Carequality joint annual meeting runs Nov. 15-17.

Suki AI and omo Ink Exclusive Partnership to Offer AI Assistant to 1000+ Clinicians

Retrieved on: 
Wednesday, December 13, 2023

REDWOOD CITY, Calif., Dec. 13, 2023 /PRNewswire/ -- Suki, the leader in voice artificial intelligence (AI) technology for healthcare, announced today an exclusive partnership with omo, a subsidiary of Hoag Health, to further its mission of lifting the administrative burden off clinicians and alleviating burnout through innovative AI solutions.

Key Points: 
  • As generative AI makes inroads in healthcare, Suki is at the forefront of the mass adoption of the technology.
  • Suki's flagship product, Suki Assistant, leverages generative AI to listen to clinician-patient exchanges in real time and create suggestions for clinical notes.
  • Through this exclusive partnership, omo and Suki will deliver a best-in-class AI assistant to over 1,000 clinicians to preserve the independent practice of medicine and improve the work-life balance.
  • With this partnership, Suki and omo will tackle the problems of documentation burden and financial pressure at scale across omo's membership.

Healthcare Executive Angela Single Joins Novari Health

Retrieved on: 
Tuesday, November 21, 2023

LONDON, Nov. 21, 2023 /PRNewswire/ -- Novari Health is pleased to announce that Angela Single has joined Novari as Director, UK Business Development.

Key Points: 
  • LONDON, Nov. 21, 2023 /PRNewswire/ -- Novari Health is pleased to announce that Angela Single has joined Novari as Director, UK Business Development.
  • Angela is a seasoned executive in the field of digital health.
  • John Sinclair, Chief Executive Officer of Novari Health UK Ltd., commented "Angela's clinical, administrative, and digital health experience make her an invaluable addition to the Novari global team, and we are thrilled to welcome her as our director of UK business development.
  • From its beginnings in Canada in 2003, Novari Health has focused exclusively on helping publicly funded healthcare systems to improve access to care.

Enovix Announces Third Quarter 2023 Financial Results

Retrieved on: 
Tuesday, November 7, 2023

FREMONT, Calif., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Enovix Corporation (“Enovix”) (Nasdaq: ENVX), an advanced silicon battery company, announced today financial results for the third quarter of 2023, which included the summary below from its President and CEO, Dr. Raj Talluri.

Key Points: 
  • FREMONT, Calif., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Enovix Corporation (“Enovix”) (Nasdaq: ENVX), an advanced silicon battery company, announced today financial results for the third quarter of 2023, which included the summary below from its President and CEO, Dr. Raj Talluri.
  • Our GAAP operating expenses of $33.8 million in the third quarter of 2023 were down from $37.7 million in the second quarter of 2023.
  • Our non-GAAP operating expenses of $18.8 million in the third quarter of 2023 were down from $19.9 million in the first quarter of 2023.
  • Enovix will hold a video conference call at 2:00 PM PT / 5:00 PM ET today, November 7, 2023, to discuss the company’s business updates and financial results.

Suki Expands Leadership Position in Ambient Clinical Documentation with the Addition of 20+ Practices

Retrieved on: 
Tuesday, October 31, 2023

REDWOOD CITY, Calif., Oct. 31, 2023 /PRNewswire/ -- Suki, the leader in voice artificial intelligence (AI) technology for healthcare, today announces the expansion of its ambient clinical documentation solution to over 20 independent practices including Capital City Primary and Immediate Care, Silicon Valley Podiatry Group, Bay Area House Calls, Elite Foot and Ankle, Tinovus Health, and more. This news not only solidifies Suki as the leader in the space but showcases the growing demand for AI-powered tools that help lift the administrative burden of clinicians.

Key Points: 
  • Suki's strong position in the market can be seen by its mass adoption across a variety of specialties.
  • "At Suki, we aim to design products and solutions that work in service of the clinician," said Punit Soni, Suki CEO and founder.
  • In addition to ambient, Suki has dictation and command modes, making it an all-in-one solution with unparalleled flexibility.
  • "Suki does a great job at creating documentation and only seems to be getting better," said Dr. Stefan Huber, a family medicine physician with Tinovus Health.

Suki Becomes the Only AI Voice Assistant to Support Inpatient Care

Retrieved on: 
Thursday, October 19, 2023

Suki , the leader in voice artificial intelligence (AI) technology for healthcare, announced today the expansion of its voice assistant’s capabilities to support inpatient care.

Key Points: 
  • Suki , the leader in voice artificial intelligence (AI) technology for healthcare, announced today the expansion of its voice assistant’s capabilities to support inpatient care.
  • Deep integration with EHRs like Epic and Cerner has allowed Suki to support clinicians in a broad swath of settings including ambulatory, telehealth, skilled nursing facilities/home health, and now, inpatient.
  • "Our vision at Suki has always been to transform healthcare through cutting-edge technology and intuitive design,” said Punit Soni, Suki CEO and Founder.
  • “Clinicians who work in the hospital have been neglected when it comes to voice assistant solutions.

Enovix Batteries Chosen for FDA-Approved Accurate Mini Blood Pressure Monitor

Retrieved on: 
Monday, September 25, 2023

FREMONT, Calif., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Enovix Corporation (“Enovix”) (Nasdaq: ENVX), an advanced silicon battery company, today announced its standard IoT and Wearable-sized batteries have been chosen by Accurate Meditech for their Class II FDA-Approved “Mini” multi-vital sign monitor.

Key Points: 
  • FREMONT, Calif., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Enovix Corporation (“Enovix”) (Nasdaq: ENVX), an advanced silicon battery company, today announced its standard IoT and Wearable-sized batteries have been chosen by Accurate Meditech for their Class II FDA-Approved “Mini” multi-vital sign monitor.
  • The Accurate Mini continuously monitors blood pressure, pulse rate and other vital signs.
  • With an Enovix battery, the Mini is anticipated to last over four months on a single charge, a 35% improvement compared to standard graphite batteries.
  • “We are proud to collaborate with Accurate Meditech to push the boundaries of non-invasive health monitoring and battery life for IoT and wearable devices like the Accurate Mini,” said Dr. Raj Talluri, President & CEO of Enovix.

Novari Health's Integration with Epic Improves Referral & Central Intake Systems

Retrieved on: 
Tuesday, September 12, 2023

Novari's integration with eReferral and Hospital EHR systems enables end-to-end central intake models.

Key Points: 
  • Novari's integration with eReferral and Hospital EHR systems enables end-to-end central intake models.
  • The software's unique ability to enable customized local workflows for clinical pathways and central intake processes have resulted in Novari being the leading referral management & central intake solution provider in Canada.
  • Referrals are then digitally received, triaged, and processed by specialized regional central intake staff using the Novari referral management technology.
  • Novari is the only system that can support complex regional workflows, integration with eReferral systems (e.g., OceanMD), fax referrals, and bidirectional integration with hospital EHR systems (e.g., Epic, Oracle Cerner, Meditech, etc.).

Yuexiu REIT Demonstrates Asset Resilience, High-Quality Assets Enhance Defensiveness, Strong Fundamentals Foster Long-Term Value

Retrieved on: 
Tuesday, August 15, 2023

HONG KONG, Aug 15, 2023 - (ACN Newswire) - Yuexiu Real Estate Investment Trust ("Yuexiu REIT", together with Yuexiu REIT Asset Management Limited, collectively known as the "REIT"; stock code: 405) announced its interim results for the six months ended 30 June 2023.

Key Points: 
  • HONG KONG, Aug 15, 2023 - (ACN Newswire) - Yuexiu Real Estate Investment Trust ("Yuexiu REIT", together with Yuexiu REIT Asset Management Limited, collectively known as the "REIT"; stock code: 405) announced its interim results for the six months ended 30 June 2023.
  • - Interim operating revenue of the GZIFC complex was RMB503.8 million, accounting for 47.4% of the REIT's total revenue.
  • Four Seasons Hotel and Ascott Serviced Apartments saw year-on-year increases in their average occupancy rates and average room rates.
  • - Yuexiu Financial Tower posted an operating revenue of approximately RMB200.2 million, representing 18.9% of the REIT's total revenue.